Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zimvie Inc. (ZIMV:NASDAQ), powered by AI.
Zimvie Inc. is currently trading at $18.99. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zimvie Inc. on Alpha Lenz.
Zimvie Inc.'s P/E ratio is -20.1.
“Zimvie Inc. trades at a P/E of -20.1 (undervalued) with modest ROE of -6.5%.”
Ask for details →Zimvie Inc. is a specialized healthcare company that operates in the medical devices industry. The primary focus of Zimvie is the design, development, and distribution of innovative solutions for the spine and dental markets. This company plays a significant role in advancing healthcare technologies by providing products that aim to improve patient outcomes in orthopedics and dental care. Key features of Zimvie's offerings include implants, instruments, biologics, and digital dentistry solutions that cater to various healthcare needs. Its products are utilized widely across hospitals, clinics, and dental practices, impacting both the orthopedic and dental sectors profoundly. As a prominent player in the healthcare market, Zimvie Inc. contributes to the evolving landscape of medical technology and patient care, holding an important position in the ecosystem of healthcare solutions providers.
“Zimvie Inc. trades at a P/E of -20.1 (undervalued) with modest ROE of -6.5%.”
Ask for details →Zimvie Inc. (ticker: ZIMV) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 1,770 employees. Market cap is $520M.
The current price is $18.99 with a P/E ratio of -20.15x and P/B of 1.36x.
ROE is -6.53% and operating margin is -0.47%. Annual revenue is $450M.